Product Information
ZOLMITRIPTAN 5 MG NASAL SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $43.4063 per EA under NDC 45802071191. Its NADAC has been published 233 times since Jan 12, 2022.
The High Outlier badge above means this manufacturer's average price in the zolmitriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802071191
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Last Updated
6/17/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA212469On Market Since
11/16/2021
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has been published 233 times since Jan 12, 2022, and over the history we have for it it has declined 43.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.4063 per EA |
|---|---|
| All-time high | $80.8103 (Nov 16, 2022) |
| All-time low | $38.6728 (Nov 19, 2025) |
| 52-week high | $48.7094 |
| 52-week low | $38.6728 |
| Median price | $63.7512 |
| Average price | $61.7237 |
| Largest weekly change | -33.7% (Apr 17, 2024) |
| Weeks tracked | 233 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 5 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG NASAL SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $43.4063 per EA (NDC 45802071191), effective Jun 24, 2026.
How has the price of ZOLMITRIPTAN 5 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has declined 43.8%. It has been tracked across 233 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG NASAL SPRAY?
Since Jan 12, 2022, the NADAC for ZOLMITRIPTAN 5 MG NASAL SPRAY has ranged from a low of $38.6728 (Nov 19, 2025) to a high of $80.8103 (Nov 16, 2022), with a median of $63.7512 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 5 MG NASAL SPRAY?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ZOLMITRIPTAN 5 MG ODT, is $2.7713 per EA — about 94% below ZOLMITRIPTAN 5 MG NASAL SPRAY.
Who manufactures ZOLMITRIPTAN 5 MG NASAL SPRAY?
ZOLMITRIPTAN 5 MG NASAL SPRAY (NDC 45802071191) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification